Use Of (+)-2-Borneol In Preparation Of Drug For Promoting Upregulation Of Expression Of Sphingosine Kinase-1 And/Or BDNF
Disclosed is the use of (+)-2-borneol in the preparation of a drug for promoting the upregulation of the expression of sphingosine kinase-1 and/or BDNF (a brain-derived neurotrophic factor). Herein, (+)-2-borneol can be used to prepare a drug for promoting the upregulation of the expression of the s...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | YU, Yunhui JIANG, Chuanliang LI, Yunsen DENG, Shiping LI, Yong |
| description | Disclosed is the use of (+)-2-borneol in the preparation of a drug for promoting the upregulation of the expression of sphingosine kinase-1 and/or BDNF (a brain-derived neurotrophic factor). Herein, (+)-2-borneol can be used to prepare a drug for promoting the upregulation of the expression of the sphingosine kinase-1 and/or the brain-derived neurotrophic factor. The drug can induce astrocyte spreading and migration, oligodendrocyte differentiation and survival, and neurite growth and nerve regeneration, and can promote the upregulation of the expression of the brain-derived neurotrophic factor, promote the survival of neurons and the growth of axons, inhibit the expansion of the infarct volume, and achieve the effect of repairing damage at the site of an immediate injury while preventing further expansion of the infarct area to completely treat brain damage, so that the long-term therapeutic effect thereof is significantly improved. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2020261375A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2020261375A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2020261375A13</originalsourceid><addsrcrecordid>eNqNisEKgkAURd20iOofHrQpYiiVaq2pFEEF5lqGetqAvTfMKPj5TSCt4y4u99wz9vrCIlwrWKyWIhAxG0Ju4ERwM6ilka1i-v6J6WrI2DjOb24V1VBog3XX_JS0d8DaYeX65SS2ihDOiqRF4UNEz_XVQJxcsqk3qmRjcTb0xJtn6f1wFKi5RKvlAwnbssiDjcvOD_fbyA__sz52jkNl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Use Of (+)-2-Borneol In Preparation Of Drug For Promoting Upregulation Of Expression Of Sphingosine Kinase-1 And/Or BDNF</title><source>esp@cenet</source><creator>YU, Yunhui ; JIANG, Chuanliang ; LI, Yunsen ; DENG, Shiping ; LI, Yong</creator><creatorcontrib>YU, Yunhui ; JIANG, Chuanliang ; LI, Yunsen ; DENG, Shiping ; LI, Yong</creatorcontrib><description>Disclosed is the use of (+)-2-borneol in the preparation of a drug for promoting the upregulation of the expression of sphingosine kinase-1 and/or BDNF (a brain-derived neurotrophic factor). Herein, (+)-2-borneol can be used to prepare a drug for promoting the upregulation of the expression of the sphingosine kinase-1 and/or the brain-derived neurotrophic factor. The drug can induce astrocyte spreading and migration, oligodendrocyte differentiation and survival, and neurite growth and nerve regeneration, and can promote the upregulation of the expression of the brain-derived neurotrophic factor, promote the survival of neurons and the growth of axons, inhibit the expansion of the infarct volume, and achieve the effect of repairing damage at the site of an immediate injury while preventing further expansion of the infarct area to completely treat brain damage, so that the long-term therapeutic effect thereof is significantly improved.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200820&DB=EPODOC&CC=US&NR=2020261375A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200820&DB=EPODOC&CC=US&NR=2020261375A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YU, Yunhui</creatorcontrib><creatorcontrib>JIANG, Chuanliang</creatorcontrib><creatorcontrib>LI, Yunsen</creatorcontrib><creatorcontrib>DENG, Shiping</creatorcontrib><creatorcontrib>LI, Yong</creatorcontrib><title>Use Of (+)-2-Borneol In Preparation Of Drug For Promoting Upregulation Of Expression Of Sphingosine Kinase-1 And/Or BDNF</title><description>Disclosed is the use of (+)-2-borneol in the preparation of a drug for promoting the upregulation of the expression of sphingosine kinase-1 and/or BDNF (a brain-derived neurotrophic factor). Herein, (+)-2-borneol can be used to prepare a drug for promoting the upregulation of the expression of the sphingosine kinase-1 and/or the brain-derived neurotrophic factor. The drug can induce astrocyte spreading and migration, oligodendrocyte differentiation and survival, and neurite growth and nerve regeneration, and can promote the upregulation of the expression of the brain-derived neurotrophic factor, promote the survival of neurons and the growth of axons, inhibit the expansion of the infarct volume, and achieve the effect of repairing damage at the site of an immediate injury while preventing further expansion of the infarct area to completely treat brain damage, so that the long-term therapeutic effect thereof is significantly improved.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNisEKgkAURd20iOofHrQpYiiVaq2pFEEF5lqGetqAvTfMKPj5TSCt4y4u99wz9vrCIlwrWKyWIhAxG0Ju4ERwM6ilka1i-v6J6WrI2DjOb24V1VBog3XX_JS0d8DaYeX65SS2ihDOiqRF4UNEz_XVQJxcsqk3qmRjcTb0xJtn6f1wFKi5RKvlAwnbssiDjcvOD_fbyA__sz52jkNl</recordid><startdate>20200820</startdate><enddate>20200820</enddate><creator>YU, Yunhui</creator><creator>JIANG, Chuanliang</creator><creator>LI, Yunsen</creator><creator>DENG, Shiping</creator><creator>LI, Yong</creator><scope>EVB</scope></search><sort><creationdate>20200820</creationdate><title>Use Of (+)-2-Borneol In Preparation Of Drug For Promoting Upregulation Of Expression Of Sphingosine Kinase-1 And/Or BDNF</title><author>YU, Yunhui ; JIANG, Chuanliang ; LI, Yunsen ; DENG, Shiping ; LI, Yong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2020261375A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YU, Yunhui</creatorcontrib><creatorcontrib>JIANG, Chuanliang</creatorcontrib><creatorcontrib>LI, Yunsen</creatorcontrib><creatorcontrib>DENG, Shiping</creatorcontrib><creatorcontrib>LI, Yong</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YU, Yunhui</au><au>JIANG, Chuanliang</au><au>LI, Yunsen</au><au>DENG, Shiping</au><au>LI, Yong</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Use Of (+)-2-Borneol In Preparation Of Drug For Promoting Upregulation Of Expression Of Sphingosine Kinase-1 And/Or BDNF</title><date>2020-08-20</date><risdate>2020</risdate><abstract>Disclosed is the use of (+)-2-borneol in the preparation of a drug for promoting the upregulation of the expression of sphingosine kinase-1 and/or BDNF (a brain-derived neurotrophic factor). Herein, (+)-2-borneol can be used to prepare a drug for promoting the upregulation of the expression of the sphingosine kinase-1 and/or the brain-derived neurotrophic factor. The drug can induce astrocyte spreading and migration, oligodendrocyte differentiation and survival, and neurite growth and nerve regeneration, and can promote the upregulation of the expression of the brain-derived neurotrophic factor, promote the survival of neurons and the growth of axons, inhibit the expansion of the infarct volume, and achieve the effect of repairing damage at the site of an immediate injury while preventing further expansion of the infarct area to completely treat brain damage, so that the long-term therapeutic effect thereof is significantly improved.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2020261375A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Use Of (+)-2-Borneol In Preparation Of Drug For Promoting Upregulation Of Expression Of Sphingosine Kinase-1 And/Or BDNF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T01%3A09%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YU,%20Yunhui&rft.date=2020-08-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2020261375A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |